Kinnos

Kinnos is a healthcare technology company that makes disinfecting easier and more reliable by adding a temporary color indicator to existing disinfectants and wipes so users can *see* coverage and proper technique in real time[5].

High‑Level Overview

• Mission: Kinnos’ stated mission is to raise the standard of infection prevention by enabling correct disinfectant use and real‑time quality control in healthcare and other high‑risk environments[5][3].
  - What product it builds: Kinnos builds Highlight, a patent‑pending color additive and related delivery systems that temporarily colorizes disinfectant solutions and wipes to show where disinfectant has been applied and when adequate mechanical action has been used[1][5].
  - Who it serves: The product targets hospitals, long‑term care, laboratories, emergency response teams, transportation hubs, and other organizations responsible for routine and outbreak disinfection[3][5].
  - Problem it solves: Highlight addresses the gap between disinfectant efficacy in lab settings and poor real‑world application by eliminating human error and providing visual feedback for surface coverage and wiping technique[1][5].
  - Growth momentum: Since its 2014 founding, Kinnos has progressed from an academic project to a commercial company with seed funding, ISO certifications, partnerships and pilots in healthcare systems, product extensions (e.g., Highlight Wipes), industry awards and Time magazine recognition in 2023, and recent patents filed in 2024–2025 indicating continued product development and commercial traction[1][3][4][5].

Origin Story

• Founders and background: Kinnos was founded in 2014 by Columbia University students Jason Kang, Katherine Jin, and Kevin Tyan after a campus design challenge responding to the 2014 West African Ebola outbreak[1][3].
  - How the idea emerged: The founders observed that disinfectants known to be effective in the lab were often used improperly in the field, so they developed a color additive (Highlight) to provide immediate visual confirmation of disinfectant coverage and adequate wiping action[1][5].
  - Early traction and pivotal moments: Early recognition and support included participation in university innovation programs and seed financing (a $1M seed round in 2017 led by Georgica Advisors), followed by manufacturing partnerships, pilot deployments in hospitals, product extensions (Highlight Wipes), awards and media recognition that helped scale the company beyond its student‑team origins[1][3][2].

Core Differentiators

• Visual, behavior‑changing technology: Highlight’s core differentiator is *colorized* disinfectant that leaves a bright trace and then fades as proper wiping and friction occur, directly tying visual feedback to correct technique[1][5].
  - Compatibility and low workflow disruption: The additive is formulated to work with common bleach, quaternary ammonium, and peroxide wipes and solutions so facilities can adopt it without replacing existing disinfectants[5][2].
  - Regulatory and IP posture: Kinnos has pursued patents on pigmented disinfection additives and related methods (patents filed/issued recently), strengthening defensibility around their approach[4].
  - Operational focus and partnerships: The company emphasizes real‑world implementation—ISO processes, manufacturing partnerships, pilot studies with health systems, and product adaptations (e.g., wipes lid and cartridges) to fit operational needs[2][5].
  - Attention to adoption barriers: By designing for untrained users and emphasizing behavior change rather than a novel disinfectant chemistry, Kinnos lowers training and procurement barriers that slow adoption of other infection‑control innovations[1][3].

Role in the Broader Tech & Health Landscape

• Trend alignment: Kinnos rides the infection‑prevention and healthcare quality trend emphasizing outcomes, not just products — shifting focus from “what disinfectant is used” to “how it’s used” and measurable compliance[5][3].
  - Why timing matters: Global experience with Ebola and COVID‑19 heightened demand for reliable, scalable infection‑control tools; facilities now prioritize practical solutions that improve frontline worker safety and reduce HAIs (hospital‑acquired infections)[1][3].
  - Market forces in their favor: Increased hospital quality reporting, outbreak preparedness funding, and attention to environmental cleaning efficacy create a receptive market for performance‑enabling additives and consumables[5].
  - Ecosystem influence: Kinnos demonstrates a path for “behavioral” adjunct technologies—small, low‑cost additions to existing workflows that produce measurable safety gains—potentially influencing procurement thinking and accelerating adoption of other complementary infection‑prevention tools[3][5].

Quick Take & Future Outlook

• What's next: Expect continued product diversification (wipes systems and solutions tuned to different chemistries), expanded hospital and international rollouts, additional clinical studies quantifying reductions in contamination/HAIs, and commercialization activities supported by issued patents and partnerships[4][5][3].
  - Trends that will shape them: Regulatory emphasis on infection prevention metrics, demand for demonstrable cleaning outcomes, and institutional budgets for patient‑safety innovations will drive adoption; supply‑chain resilience and cost pressures will shape pricing and scale strategies[5][3].
  - How influence may evolve: If Kinnos’ pilots and studies continue to show measurable reductions in surface contamination and outbreaks, the company could become a standard component of disinfection protocols and a model for low‑friction behavior‑change technologies in healthcare[5][1].

Quick take: Kinnos took a simple, human‑centered insight—make disinfecting visible—and turned it into a commercially viable, defensible product that reduces reliance on training alone to achieve proper cleaning; the company’s challenge going forward will be proving consistent clinical outcomes at scale and embedding Highlight into institutional purchasing and standards so the behavior change becomes routine[1][5][3].